Opportunity overview
Project title: NHS National Framework for Transition products commencing 1 February 2025<br/>Offer reference number: CM/TNS/24/5713<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection<br/><br/>Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Sun Pharma UK Ltd
- Contract value
- £1
- Awarded
- Not supplied
- Contract signed
- 14 Jan 2025
- Award ID
- 002071-2025-1
- Status
- active
- Identifier
- 02992795
- Location
- Uxbridge, UK, UB11 1FW, United Kingdom
Thornton and Ross Ltd
- Contract value
- £1
- Awarded
- Not supplied
- Contract signed
- 14 Jan 2025
- Award ID
- 002071-2025-2
- Status
- active
- Identifier
- 00185947
- Location
- Huddersfield, UK, HD7 5QH, United Kingdom
Dr.Reddy's Laboratories (UK) Limited
- Contract value
- £1
- Awarded
- Not supplied
- Contract signed
- 14 Jan 2025
- Award ID
- 002071-2025-3
- Status
- active
- Identifier
- 1729064
- Location
- Cambridge, UK, CB4 0PE, United Kingdom
Zentiva Pharma UK Ltd
- Contract value
- £1
- Awarded
- Not supplied
- Contract signed
- 14 Jan 2025
- Award ID
- 002071-2025-4
- Status
- active
- Identifier
- 2158996
- Location
- London, UK, EC4A 1JP, United Kingdom
Biocon
- Contract value
- £1
- Awarded
- Not supplied
- Contract signed
- 14 Jan 2025
- Award ID
- 002071-2025-5
- Status
- active
- Identifier
- 11716196
- Location
- London, United Kingdom,, UK, WC2B 5AH, United Kingdom
Baxter Healthcare Ltd
- Contract value
- £1
- Awarded
- Not supplied
- Contract signed
- 14 Jan 2025
- Award ID
- 002071-2025-6
- Status
- active
- Identifier
- 00461365
- Location
- Norfolk,, UK, IP24 3SE, United Kingdom
Classification
- CPV33600000 — Pharmaceutical products
Lots
- Project title: NHS National Framework for Transition products commencing 1 February 2025<br/>Offer reference number: CM/TNS/24/5713<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection<br/><br/>Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England£28.3m